CRP and hematologic disorder: In regard to the latter, several real-world studies carried out, mainly in patients with hematological malignancies undergoing hematopoietic stem cell/bone marrow transplantation and/or in solid organ transplant recipients, showed in the last decade that thresholds of inflammatory biomarkers like CRP or PCT may be significantly associated with toxic voriconazole levels [14].